Who Should Approach GHK-Cu with Caution Individuals with known copper sensitivity, Wilson's disease, or active systemic inflammation should discuss GHK-Cu with a qualified healthcare provider before use
Sikiric et al., 2020b), along with suggested significance of NO-synthase and the basal formation of NO in stomach mucosa, greater than that seen in other tissues (Whittle et al., 1992), BPC 157 exhibits a general, effective competing with both L-arginine analogs (i.e., L-NAME) and L-arginine (Sikiric et al., 2014)
Regulatory documentation provided by Hongda Phytochemistry includes Certificates of Analysis, Material Safety Data Sheets, and REACH compliance documentation that facilitate regulatory submissions and import clearances in various jurisdictions
Expression of leucocyte adhesion molecules at the human blood-brain barrier (BBB)
Individuals who are pregnant or breastfeeding, those with a history of certain cancers (due to the peptides ability to stimulate blood vessel growth), or those with copper metabolism disorders such as Wilsons disease should avoid this therapy